Comparison of Two Different Endoscopic Radial Artery Harvesting Devices

NCT03023475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-02-25

No results posted yet for this study

Summary

Endoscopic radial artery harvesting in coronary bypass surgery is routinely performed by the investigators. In this study, the investigators want to compare the MiFusion TLS2 (Endotrust GmbH, Germany) device to the LigaSure Maryland Jaw (Medtronic, USA). The vessel harvesting is performed in the standard fashion according to the institutional routine. The patients are randomized preoperatively to one of the devices. The proximal end of the radial artery will be preserved and deep-frozen for histological assessment. Endothelial integrity will be investigated using Hematoxylin-Eosin, CD31 and endothelial nitrogen monoxide synthase.

Conditions

  • CABG Graft Integrity

Interventions

DEVICE

LigaSure endoscopic vessel harvesting

The radial artery will be harvested endoscopically using the LigaSure system.

DEVICE

TLS2 endoscopic vessel harvesting

The radial artery will be harvested endoscopically using the TLS2 system.

Sponsors & Collaborators

  • Kerckhoff Klinik

    lead OTHER

Principal Investigators

  • Arnaud Van Linden, MD · Kerckhoff Klinik

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-09-30
Completion
2018-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03023475 on ClinicalTrials.gov